JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 51 filers reported holding JANUX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,942,265 | -12.6% | 192,685 | +2.9% | 0.00% | – |
| Q2 2023 | $2,223,132 | +31.3% | 187,290 | +33.8% | 0.00% | – |
| Q1 2023 | $1,693,650 | -8.0% | 139,971 | +0.2% | 0.00% | – |
| Q4 2022 | $1,840,218 | -0.4% | 139,728 | +2.5% | 0.00% | – |
| Q3 2022 | $1,847,000 | +13.7% | 136,364 | +2.4% | 0.00% | – |
| Q2 2022 | $1,625,000 | -19.2% | 133,157 | -5.1% | 0.00% | – |
| Q1 2022 | $2,011,000 | -11.8% | 140,247 | +21.4% | 0.00% | – |
| Q4 2021 | $2,279,000 | -9.9% | 115,495 | -1.3% | 0.00% | – |
| Q3 2021 | $2,530,000 | – | 116,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |